NEW YORK (GenomeWeb News) – Cancer Genetics today announced it has reached a deal with a second preferred provider organization.

The Rutherford, NJ-based firm has executed an agreement with Three Rivers Provider Network, providing about 15 million of the PPO's members access to Cancer Genetics' testing menu. The deal follows an agreement that Cancer Genetics inked with MultiPlan in May 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.